Login

BMS 299897

CAT:
804-HY-50883-04
Size:
25 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
BMS 299897 - image 1

BMS 299897

  • CAS Number: 290315-45-6
  • UNSPSC Description: BMS 299897 is a sulfonamide γ-secretase inhibitor with an IC50 of 7 nM for Aβ production inhibition in HEK293 cells stably overexpressing amyloid precursor protein (APP).
  • Target Antigen: γ-secretase
  • Type: Reference compound
  • Related Pathways: Neuronal Signaling;Stem Cell/Wnt
  • Applications: Neuroscience-Neurodegeneration
  • Field of Research: Neurological Disease
  • Assay Protocol: https://www.medchemexpress.com/BMS-299897.html
  • Purity: 99.64
  • Solubility: DMSO : ≥ 30 mg/mL
  • Smiles: FC1=CC=C(F)C(N([C@@H](C2=C(CCCC(O)=O)C=C(F)C=C2)C)S(C3=CC=C(Cl)C=C3)(=O)=O)=C1
  • Molecular Weight: 511.94
  • References & Citations: [1]Meunier J, et al. The γ-secretase inhibitor 2-[(1R)-1-[(4-chlorophenyl)sulfonyl](2,5-difluorophenyl) amino]ethyl-5-fluorobenzenebutanoic acid (BMS-299897) alleviates Aβ1-42 seeding and short-term memory deficits in the Aβ25-35 mouse model of Alzheimer's d|[2]Weissmiller AM, et al. A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APP. PLoS One. 2015 Feb 24;10(2):e0118379.
  • Shipping Conditions: Room Temperature
  • Storage Conditions: -20°C, 3 years; 4°C, 2 years (Powder)
  • Clinical Information: No Development Reported